$CERS gap & now FDA Pr. $6.16 FDA Approves INTERCEPT

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$CERS gap & now FDA Pr. $6.16
FDA Approves INTERCEPT Blood System for Platelets 7:45 PM


100% Buy

850318709_barchart_logo1.jpg

clientlogo.jpg
Website

Shares Outstanding: 78.27M
Float: 57.90M

% Held by Insiders: 1.54%
% Held by Institutions: 63.50%
Shares Short (as of Nov 28, 2014): 12.12M
Short Ratio (as of Nov 28, 2014): 11.60
Short % of Float (as of Nov 28, 2014): 19.20%
Shares Short (prior month): 12.05M


yahoo_finance_en-US_s_f_p_191x21_finance_2x.png

10-Q 11/7/13
Summary

Recent Trades
599675067_stockwatch.jpg



Headlines


Thursday, December 18, 2014
FDA Approves INTERCEPT Blood System for PlateletsBusiness Wire (Thu 7:20PM EST)

Wednesday, December 17, 2014
Equity markets surge...so many stories – where to begin?Yahoo Finance Blogs (Wed, Dec 17)
Cerus jumps on FDA OK for plasma treatmentat MarketWatch (Wed, Dec 17)
Now it’s the Fed’s turn to pour grease on the market fireat MarketWatch (Wed, Dec 17)

Tuesday, December 16, 2014
5:36 pm Cerus confirms FDA approval of INTERCEPT Blood System for plasmaBriefing.com (Tue, Dec 16)
FDA Approves INTERCEPT Blood System for PlasmaBusiness Wire (Tue, Dec 16)

Friday, November 21, 2014
FDA Accepts IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent PlasmaBusiness Wire (Fri, Nov 21)

Saturday, November 15, 2014
CERUS CORP FinancialsEDGAR Online Financials (Sat, Nov 15)

Sunday, November 9, 2014
10-Q for Cerus Corp.Company Spotlight (Sun, Nov 9)

Friday, November 7, 2014
CERUS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 7)

Wednesday, November 5, 2014
Cerus (CERS) Stock: Weak On High Volume Todayat TheStreet (Wed, Nov 5)

Tuesday, November 4, 2014
Cerus posts 3Q lossAP (Tue, Nov 4)
CERUS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Tue, Nov 4)
Cerus Corporation Reports Third Quarter 2014 ResultsBusiness Wire (Tue, Nov 4)

Wednesday, October 29, 2014
Cerus Announces Agreement With Kawasumi Laboratories for the Development of INTERCEPT Platelets Kits in JapanBusiness Wire (Wed, Oct 29)

Thursday, October 23, 2014
American Red Cross to Participate in Cerus' IDE Study to Address Chikungunya and Dengue Blood Safety RisksBusiness Wire (Thu, Oct 23)

Wednesday, October 22, 2014
Cerus to Release Third Quarter 2014 Results on November 4, 2014Business Wire (Wed, Oct 22)

Tuesday, October 21, 2014
Strength Seen in Cerus (CERS): Stock Gains 6.2%Zacks (Tue, Oct 21)

Monday, October 20, 2014
Cerus Submits Compassionate Use IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent PlasmaBusiness Wire (Mon, Oct 20)

Tuesday, October 7, 2014
U.S. FDA Accepts IDE Submission by Cerus Making the INTERCEPT Blood System Available to Address Chikungunya and Dengue Blood Safety RisksBusiness Wire (Tue, Oct 7)

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 40

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 27

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 34

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 29

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Platinum: Potential for Growth in the Precious Metals Market

Updated Category News Views 135

Rising Interest in Platinum as a Precious Metal As we near the end of the year, the financial landscape is captivated by valuable metals, especially gold. Historically, gold has been the center of attention, attributed to its record-breaking prices amidst geopolitical uncertainty and substantial purchases by central banks. Yet, as the spotlight shines on gold, an equally...

Continue Reading
Micron Technology Inc Forecasts Growth in AI Memory Sector

Updated Category News Views 202

Micron Technology's Upgraded Outlook Micron Technology (NASDAQ: MU) has seen a remarkable surge in its stock performance. This is attributed to an optimistic outlook for an upcoming quarter, reflecting the booming demand for memory chips, particularly those focused on artificial intelligence (AI). Analysts have noted significant growth potential, which bodes well for the...

Continue Reading
Myomo Earnings Predictions: Investors Eye Quarterly Results

Updated Category News Views 101

Myomo Prepares for Earnings Announcement Myomo Inc (AMEX: MYO) is set to announce its quarterly earnings, prompting significant interest among investors. As the company gears up, investors should be aware of several key points that may influence stock prices and investor sentiment. What Analysts Are Predicting Analysts anticipate an earnings per share (EPS) of $-0.11 for...

Continue Reading
MiniLuxe Secures $2.7M in Funding for Strategic Growth

Updated Category News Views 166

MiniLuxe's Successful Capital Placement MiniLuxe Holding Corp. (TSXV: MNLX) has made significant strides towards achieving its growth objectives with a recent announcement regarding its capital-enhancing transactions. The company has completed an initial closing of a non-brokered private placement, raising over USD $1.6 million, while also converting USD $1.0 million of...

Continue Reading
Unique Wedding Destinations Across Latin America for Couples

Updated Category News Views 218

Trendy Options for a Destination Wedding in Latin America Marriott International presents beautiful destinations that promise to make every wedding truly unique and memorable. In a time where weddings are more about personal stories and experiences than mere traditions, couples are increasingly opting for destination weddings that resonate with their lifestyle....

Continue Reading